Zdrowie i gospodarka · 02/10/2023
FDA Announces Pilot Program to Accelerate Rare Disease Therapeutics Development
The FDA is launching a pilot program to support the development of rare disease therapeutics, with the goal of accelerating the pace of development of novel drug and biological products intended to treat rare diseases.
Source: Federal Register — Food and Drug AdministrationOpen original release →